Thyroid News

Adults with mild hyperparathyroidism who underwent a parathyroidectomy did not have a difference in fracture events at 10 years compared with adults who did not undergo surgery, according to study data.

The Healio and Endocrine Today editors have compiled the top thyroid news stories from 2022.

Few older adults who undergo total thyroidectomy for treatment of Graves’ disease developed hypoparathyroidism requiring calcitriol therapy, according to data published in Thyroid.

Individualized care and patient satisfaction are among the areas of emphasis in a new consensus statement on management of thyroid eye disease.

Overall survival rates for adults diagnosed with anaplastic thyroid carcinoma are similar between those with a history of cancer and those with no previous cancer diagnosis, according to findings published in Thyroid.

Subclinical hyperthyroidism is an independent risk factor associated with fracture among white and Black middle-aged adults, according to results from a community-based cohort study published in JAMA Network Open.

Adults with type 2 diabetes who use a GLP-1 receptor agonist for more than 1 year may have an increased risk for thyroid cancer, according to findings published in Diabetes Care.

Children aged 10 years or younger with papillary thyroid carcinoma are more likely to have more advanced disease at diagnosis than adolescents or young adults, according to a study published in Thyroid.

Studies analyzing four molecular tests commonly used to assess malignancy in thyroid nodules have high sensitivity despite several limitations, according to findings from a systematic review and meta-analysis.

Less than 5% of adults with thyroid eye disease who completed a full course of teprotumumab therapy required an additional course of the agent, according to a presenter at the American Thyroid Association annual meeting.